Dayvigo 5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FK8TS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,180
Award facts
- Contract value 100% obligated
- $1,179.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Dayvigo 5 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,179.52. This award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside designation, indicating competitive award, and specifies an ultimate completion date of November 4, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This contract delivery supports the Defense Health Agency and broader military healthcare supply chain requirements through AmerisourceBergen's established pharmaceutical distribution capabilities. Dayvigo (lemborexant) is a prescription sleep aid approved for insomnia treatment, representing the type of specialized pharmaceutical products the contractor regularly supplies to federal healthcare systems. AmerisourceBergen's comprehensive IDC with DLA Troop Support Medical enables the company to serve as a critical vendor for military and veteran healthcare systems, providing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB26FK8TS?
SPE2DB26FK8TS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FK8TS worth?
The government has obligated $1,180 on SPE2DB26FK8TS.
Is contract SPE2DB26FK8TS an order under another contract?
Yes. SPE2DB26FK8TS is a delivery order under SPE2DB22D3102, an indefinite delivery contract.
Was contract SPE2DB26FK8TS competed?
The extent of competition for SPE2DB26FK8TS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award